Compounds > bis(4-nitrophenyl)phosphate

bis(4-nitrophenyl)phosphate and tacrine

bis(4-nitrophenyl)phosphate has been researched along with tacrine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bachurin, SO; Boltneva, NP; Burgart, YV; Chupakhin, ON; Kovaleva, NV; Lushchekina, SV; Makhaeva, GF; Richardson, RJ; Rudakova, EV; Saloutin, VI; Serebryakova, OG; Shchegol'kov, EV1
Bachurin, SO; Boltneva, NP; Charushin, VN; Chupakhin, ON; Lushchekina, SV; Makhaeva, GF; Richardson, RJ; Rudakova, EV; Serebryakova, OG; Shchepochkin, AV; Ustyugov, AA1
Beloglazkin, AA; Boltneva, NP; Borisov, RS; Kulikova, LN; Lushchekina, SV; Makhaeva, GF; Richardson, RJ; Rudakova, EV; Serebryakova, OG1

Other Studies

3 other study(ies) available for bis(4-nitrophenyl)phosphate and tacrine

ArticleYear
Synthesis, molecular docking, and biological activity of polyfluoroalkyl dihydroazolo[5,1-c][1,2,4]triazines as selective carboxylesterase inhibitors.
    Bioorganic & medicinal chemistry, 2017, 08-01, Volume: 25, Issue:15

    Topics: Animals; Carboxylesterase; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Structure-Activity Relationship; Triazines

2017
9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Bioorganic & medicinal chemistry, 2017, 11-01, Volume: 25, Issue:21

    Topics: Acetylcholinesterase; Acridines; Alzheimer Disease; Animals; Antioxidants; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Horses; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship

2017
Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
    Bioorganic & medicinal chemistry, 2018, 09-01, Volume: 26, Issue:16

    Topics: Acetylcholinesterase; Alzheimer Disease; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Chromones; Humans; Kinetics; Molecular Docking Simulation; Protein Structure, Tertiary; Structure-Activity Relationship

2018